YOLFTbeta
Amoeba SA

Amoeba SA

ALMIB · PA · Basic Materials / Agricultural Inputs

0.3105EUR+0.02 (+8.19%)

Price History

Full chart

Market Stats

Previous Close0.287
Open0.287
Day Range0.2835 – 0.319
52-Week Range0.301 – 1.20
Volume955.71K
Market Cap24.58M
P/E (TTM)0.00
Forward P/E24.88
EPS-0.14
Dividend Yield0.00%
Beta0.21
50-Day Avg0.6174
200-Day Avg0.8207

About

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Jean-Francois Doucet
  • Employees23
  • Headquarters38 Avenue des FrEres Montgolfier, Chassieu, France, 69680, France
  • Websitehttps://amoeba-nature.com

Leadership

  • Mr. Jean-Francois DoucetGeneral Director
  • Mr. Jean-Marc PetatMD of Green 4 Agro & Director · b. 1964
  • Dr. Sandrine TroussieuxScientific Director

Financials

Income Statement

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue81.52K302.21K222.48K140.94125.95161.25122.28122.48K000664.31K601.60K0
Growth (%)-+270.73%-26.38%-99.94%-10.64%+28.03%-24.17%+100063.56%-100.00%----9.44%-100.00%
Cost of Revenue---262.33581.43660.65991.282.35M1.47M858.95K1.01M1.71M805.57K973.03K
Gross Profit81.52K302.21K222.48K-121.39-455.49-499.4-869.01-2.23M-1.47M-858.95K-1.01M-1.71M-805.57K-973.03K
Gross Margin100.00%100.00%100.00%-86.13%-361.64%-309.71%-710.67%-1818.62%----257.20%-133.90%-
Operating Expense303.81K795.73K1.15M3.87K5.30K5.46K4.58K3.82M5.19M5.29M5.29M12.33M6.06M7.20M
Operating Income-222.29K-493.52K-922.90K-3.99K-5.75K-5.96K-5.45K-6.04M-6.65M-6.15M-6.30M-14.04M-6.87M-8.17M
Operating Margin-272.69%-163.30%-414.82%-2829.42%-4567.76%-3698.52%-4456.59%-4934.11%----2113.21%-1141.34%-
EBITDA-148.45K-414.17K-818.55K-3.83M-5.45M-5.31M-5.48M-3.72M-5.05M-5.01M-5.35M-13.74M-5.38M-7.20M
EBITDA Margin-182.11%-137.05%-367.91%-2714211.01%-4327001.19%-3294136.43%-4484225.55%-3037.05%----2067.81%-893.70%-
Net Income-246.92K-521.09K-974.64K-4.02K-5.77K-6.23K-7.22K-7.25M-8.16M-7.82M-8.02M-14.30M-6.59M-8.30M
Net Income Margin-302.90%-172.43%-438.07%-2851.48%-4579.41%-3865.77%-5906.85%-5919.10%----2152.31%-1095.66%-
R&D390.74K679.09K970.67K1.48K2.64K2.69K1.55K1.25M1.61M2.18M2.21M2.32M2.01M1.57M
R&D as % of Total Revenue479.33%224.71%436.29%1053.62%2095.94%1667.74%1270.07%1020.08%---349.89%334.41%-
Interest Expense26.65K28.35K58.26K50.60K78.67K196.01K1.16M1.69M2.13M2.49M1.91M145.75K928.42K1.52M
Interest Expense % of Total Revenue32.69%9.38%26.19%35899.67%62458.12%121557.83%945274.78%1381.69%---21.94%154.32%-

Balance Sheet

Currency: EUR2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.26M1.72M2.24M5.55M14.13K23.31K21.58K13.92K13.84M13.06M14.50M12.39M6.29M5.65M10.13M
Total Liabilities661.17K770.75K1.80M2.75M3.54K4.69K9.06K8.51K9.61M11.06M14.30M4.23M10.23M16.06M15.49M
Total Equity597.42K947.20K433.99K2.80M10.60K18.63K12.52K5.41K4.23M2.00M198.68K8.16M-3.94M-10.41M-5.36M
Cash345.75K368.34K460.93K2.62M7.73K12.00K10.24K3.46K4.76M4.97M7.28M5.53M519.33K458.94K4.72M
Total Debt323.91K641.34K239.01K1.04M1.86M3.03M7.33M7.37M8.51M8.62M12.50M2.36M4.92M12.07M12.24M
Net Debt-21.84K273.00K-221.92K-1.58M1.85M3.02M7.32M7.37M3.75M3.64M5.22M-3.17M4.40M11.61M7.52M

Cash Flow

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-162.56K500.21K-1.19M-4.16K-5.71K-5.08K-5.33K-3.64M-3.25M-5.90M-5.40M-6.50M-4.22M-6.13M
Investing Cash Flow-470.69K-529.40K-892.91K-2.44K-3.36K-856.62-430.01-55.92K-76.93K-140.65K-212.13K-2.81M-2.01M-1.30M
Financing Cash Flow655.84K121.79K4.24M11.72K13.36K4.18K-1.02K5.00M3.54M4.98M3.87M4.30M6.16M11.69M
Capital Expenditure469.83K521.66K893.12K1.43K3.22K887.0663.173.48K61.00K144.57K305.67K6.08M564.65K1.30M
Free Cash Flow-632.39K-21.45K-2.09M-5.59K-8.93K-5.97K-5.39K-3.71M-3.52M-6.05M-5.71M-12.59M-4.78M-7.42M
FCF to OCF389.03%-4.29%174.86%134.24%156.48%117.47%101.18%102.02%108.22%102.45%105.66%193.53%113.39%121.16%

Earnings

Report DateMay 26, 2016Sep 20, 2016Apr 26, 2017Sep 21, 2017May 2, 2018Sep 21, 2018Apr 25, 2019Sep 30, 2019May 8, 2020Aug 14, 2020May 14, 2021Nov 12, 2021May 16, 2022Nov 11, 2022Apr 18, 2023Oct 7, 2024Apr 17, 2025Oct 24, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.00
EPS Actual-0.49-0.49-0.51-0.54-0.50-0.75-0.45-0.65-0.32-0.28-0.23-0.25-0.21-0.20-0.08-0.07-0.07-0.08
Surprise------------------
TimingPre-marketAfter-hoursPre-marketPre-market-After-hours-After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market---

Key Statistics & Ratios

Market Cap24.58M
Enterprise Value46.21M
Trailing P/E0.00
Forward P/E24.88
Price / Sales32.41
Price / Book3.00
EPS-0.14
Book Value-0.078
Revenue (TTM)758.45K
Gross Profit (TTM)-4.54M
EBITDA-9.51M
Profit Margin0.00%
Operating Margin-10365.08%
Return on Equity-675.58%
Return on Assets-53.73%
Shares Outstanding77.78M
Shares Float68.89M
Beta0.21
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%